Sen­a­tor Wyden prods Trump/Pfiz­er for de­tails, call­ing drug pric­ing stunt 'long on the­atrics, short on re­lief'

Sen­a­tor Ron Wyden (D-Ore­gon) on Wednes­day sought more de­tails from Pres­i­dent Don­ald Trump’s HHS Sec­re­tary and Pfiz­er on the com­pa­ny’s de­ci­sion to de­lay price in­creas­es.

In a let­ter to Pfiz­er, Wyden said, “Rolling back pre­vi­ous­ly an­nounced price in­creas­es based on a con­ver­sa­tion with the Pres­i­dent il­lus­trates how ar­bi­trary drug man­u­fac­tur­ers’ de­ci­sions to in­crease prices [are].”

Ac­cord­ing to mul­ti­ple re­ports, Pfiz­er raised the prices of about 100 prod­ucts as of Ju­ly 1, but on Tues­day said those hikes would be de­layed un­til Trump’s drug price blue­print comes in­to force — rais­ing ques­tions about what would be im­ple­ment­ed that would cause Pfiz­er to make an about face on the hikes.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER